drugset / Trial / NCT04538885
Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Poorly Healed Wounds of Postoperative Incision
Phase 1
Unknown
50 enrolled
Chinese PLA General Hospital
Gansu Provincial Maternal and Child Health Care Hospital · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Poor incision healing is a common complication after abdominal surgery, mainly manifested as incision dehiscence, subcutaneous fat liquefaction, malnutrition, and incision infection. Poor healing of the incision will increase the patient's pain and prolong the patient's hospital stay, and the choice of wound treatment is closely related to the wound healing effect. Mesenchymal stem cells mainly rely on paracrine effects to exert their therapeutic effects and obtain better therapeutic effects in wound healing. Here, the pleiotropic factors secreted from mesenchymal stem cells (MSCs-PFs) will be used to treat patients with poor healing after surgery to evaluate its effectiveness and safety.
Timeline
- Start
- 2020-09-10
- Primary completion
- 2021-03-31
- Completion
- 2021-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | The pleiotropic factor derived from mesenchymal stem cells | Unknown | 2.5 unknown | Topical |
Indications
No indication recorded.